Insider Transactions in Q3 2025 at Hims & Hers Health, Inc. (HIMS)
Insider Transaction List (Q3 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 24
2025
|
Michael Chi Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
2,100
-0.72%
|
$117,600
$56.52 P/Share
|
|
Sep 24
2025
|
Michael Chi Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,100
+0.71%
|
$10,500
$5.01 P/Share
|
|
Sep 22
2025
|
Oluyemi Okupe Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
23,584
-18.28%
|
$1,344,288
$57.74 P/Share
|
|
Sep 17
2025
|
Andrew Dudum Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
65,110
-40.59%
|
$3,255,500
$50.57 P/Share
|
|
Sep 17
2025
|
Michael Chi Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
13,749
-4.42%
|
$687,450
$50.5 P/Share
|
|
Sep 17
2025
|
Irene Becklund PAO |
SELL
Open market or private sale
|
Direct |
8,410
-85.57%
|
$420,500
$50.5 P/Share
|
|
Sep 17
2025
|
Patrick Harrison Carroll Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
10,021
-5.57%
|
$501,050
$50.5 P/Share
|
|
Sep 17
2025
|
Soleil Boughton Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
2,637
-1.56%
|
$131,850
$50.5 P/Share
|
|
Sep 16
2025
|
Andrew Dudum Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
128,127
-8.58%
|
$6,790,731
$53.65 P/Share
|
|
Sep 16
2025
|
Andrew Dudum Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
125,335
+18.74%
|
$250,670
$2.43 P/Share
|
|
Sep 16
2025
|
Andrew Dudum Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
47,534
-18.33%
|
$2,519,302
$53.38 P/Share
|
|
Sep 15
2025
|
Andrew Dudum Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
90,672
-35.71%
|
$4,805,616
$53.96 P/Share
|
|
Sep 15
2025
|
Andrew Dudum Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
164,368
+39.3%
|
-
|
|
Sep 15
2025
|
Michael Chi Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
39,872
-11.37%
|
$2,113,216
$53.96 P/Share
|
|
Sep 15
2025
|
Michael Chi Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
76,256
+4.63%
|
$533,792
$7.79 P/Share
|
|
Sep 15
2025
|
Michael Chi Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
4,150
-1.47%
|
$232,400
$56.0 P/Share
|
|
Sep 15
2025
|
Irene Becklund PAO |
SELL
Payment of exercise price or tax liability
|
Direct |
8,867
-47.43%
|
$469,951
$53.96 P/Share
|
|
Sep 15
2025
|
Irene Becklund PAO |
BUY
Exercise of conversion of derivative security
|
Direct |
17,983
+49.03%
|
-
|
|
Sep 15
2025
|
Soleil Boughton Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
22,829
-11.9%
|
$1,209,937
$53.96 P/Share
|
|
Sep 15
2025
|
Soleil Boughton Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
41,420
+17.75%
|
-
|
|
Sep 15
2025
|
Patrick Harrison Carroll Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,500
-3.49%
|
$344,500
$53.96 P/Share
|
|
Sep 15
2025
|
Patrick Harrison Carroll Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
16,521
+8.14%
|
-
|
|
Sep 15
2025
|
Kare Schultz Director |
BUY
Exercise of conversion of derivative security
|
Direct |
6,623
+29.61%
|
-
|
|
Sep 15
2025
|
Oluyemi Okupe Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
145,000
-30.21%
|
$7,975,000
$55.52 P/Share
|
|
Sep 15
2025
|
Oluyemi Okupe Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
215,199
+30.4%
|
$1,075,995
$5.01 P/Share
|
|
Sep 15
2025
|
Oluyemi Okupe Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
58,021
-26.14%
|
$3,075,113
$53.96 P/Share
|
|
Aug 26
2025
|
Oluyemi Okupe Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
11,581
-9.02%
|
$497,983
$43.69 P/Share
|
|
Aug 26
2025
|
Oluyemi Okupe Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
11,581
+8.27%
|
$57,905
$5.01 P/Share
|
|
Aug 25
2025
|
Soleil Boughton Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
2,571
-1.68%
|
$113,124
$44.53 P/Share
|
|
Aug 18
2025
|
Andrew Dudum Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
128,127
-17.55%
|
$5,765,715
$45.04 P/Share
|
|
Aug 18
2025
|
Andrew Dudum Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
125,335
+24.57%
|
$250,670
$2.43 P/Share
|
|
Aug 18
2025
|
Andrew Dudum Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
47,534
-25.0%
|
$2,139,030
$45.05 P/Share
|
|
Aug 13
2025
|
Oluyemi Okupe Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
11,581
-9.02%
|
$555,888
$48.05 P/Share
|
|
Aug 13
2025
|
Oluyemi Okupe Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
11,581
+14.99%
|
$57,905
$5.01 P/Share
|
|
Aug 11
2025
|
Soleil Boughton Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
2,572
-1.65%
|
$131,172
$51.64 P/Share
|
|
Aug 07
2025
|
Andrew Dudum Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
660,000
-22.96%
|
$33,000,000
$50.58 P/Share
|
|
Aug 06
2025
|
Patrick Harrison Carroll Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
60,000
-26.09%
|
$3,180,000
$53.58 P/Share
|
|
Aug 01
2025
|
Michael Chi Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
250
-0.09%
|
$16,000
$64.44 P/Share
|
|
Aug 01
2025
|
Michael Chi Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
250
+0.09%
|
$2,750
$11.53 P/Share
|
|
Jul 31
2025
|
Michael Chi Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
26,350
-8.64%
|
$1,765,450
$67.0 P/Share
|
|
Jul 31
2025
|
Michael Chi Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
26,350
+2.15%
|
$237,150
$9.32 P/Share
|
|
Jul 28
2025
|
Soleil Boughton Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
2,572
-1.63%
|
$149,176
$58.7 P/Share
|
|
Jul 24
2025
|
Michael Chi Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
2,100
-0.75%
|
$119,700
$57.52 P/Share
|
|
Jul 24
2025
|
Michael Chi Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,100
+0.74%
|
$10,500
$5.01 P/Share
|
|
Jul 23
2025
|
Michael Chi Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
13,750
-4.7%
|
$770,000
$56.0 P/Share
|
|
Jul 23
2025
|
Michael Chi Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
13,750
+1.51%
|
$96,250
$7.79 P/Share
|
|
Jul 21
2025
|
Andrew Dudum Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
125,335
-24.27%
|
$6,141,415
$49.5 P/Share
|
|
Jul 21
2025
|
Andrew Dudum Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
125,335
+19.11%
|
$250,670
$2.43 P/Share
|
|
Jul 16
2025
|
Andrew Dudum Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
47,534
-10.06%
|
$2,376,700
$50.53 P/Share
|
|
Jul 16
2025
|
Andrew Dudum Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
2,792
-2.94%
|
$139,600
$50.58 P/Share
|